Amino.Desk

Humanin

Updated Nov 17, 2026 · Clinical review: pending

Humanin is a small peptide made by mitochondria, the energy-producing parts of the cell. Natural levels fall with age, which is why it is sold as a longevity peptide. No trial has tested giving it to people.

What it is

A peptide of 24 amino acids, discovered in 2001 and encoded in mitochondrial DNA. It was the first of a family that also includes MOTS-c. In cells and animals it protects against several kinds of stress.

What the evidence shows

The human evidence is observational. Circulating humanin declines with age, runs higher in the children of centenarians, and is lower in Alzheimer's disease. Those are associations with a natural marker. They do not show that adding humanin helps.

Most animal work used a stronger laboratory analog, not the natural peptide. The Alzheimer's Drug Discovery Foundation's review says clinical testing in humans has not been conducted and no therapeutic dose has been established.

Legal status

Reported dosing

We do not publish a protocol for this compound.

No dose has been established in people.

Safety

Common questions

What is humanin?

A 24-amino-acid peptide made by mitochondria that protects cells under stress.

Has humanin been tested in people?

Only by measuring natural levels. No trial has given it to people as a treatment.

Is humanin related to MOTS-c?

Yes. Both are mitochondrial-derived peptides.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy